Biocon-Mylan Prime Pegfilgrastim Market Expansion
US Approves Biocon’s sBLA for New Pegfilgrastim Facility
Biocon-Mylan’s sBLA approval for pegfilgrastim made at a new Indian site gets FDA go-ahead, facilitating a "multi-fold" scale up in capacity. But it will be interesting to watch how impactful this could be on market dynamics in the US, where more competition has arrived.
